nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—SHBG—seminiferous tubule of testis—germ cell cancer	0.0815	0.246	CbGeAlD
Etonogestrel—PGR—blood vessel—germ cell cancer	0.0154	0.0464	CbGeAlD
Etonogestrel—CYP3A4—urine—germ cell cancer	0.0124	0.0374	CbGeAlD
Etonogestrel—SHBG—neck—germ cell cancer	0.0122	0.0368	CbGeAlD
Etonogestrel—ESR1—blood vessel—germ cell cancer	0.012	0.0363	CbGeAlD
Etonogestrel—SHBG—brainstem—germ cell cancer	0.00932	0.0281	CbGeAlD
Etonogestrel—ESR1—neck—germ cell cancer	0.0086	0.026	CbGeAlD
Etonogestrel—ESR1—embryo—germ cell cancer	0.00717	0.0216	CbGeAlD
Etonogestrel—PGR—decidua—germ cell cancer	0.00706	0.0213	CbGeAlD
Etonogestrel—SHBG—gonad—germ cell cancer	0.00691	0.0208	CbGeAlD
Etonogestrel—SHBG—uterus—germ cell cancer	0.00686	0.0207	CbGeAlD
Etonogestrel—SHBG—pituitary gland—germ cell cancer	0.00674	0.0203	CbGeAlD
Etonogestrel—ESR1—brainstem—germ cell cancer	0.00657	0.0198	CbGeAlD
Etonogestrel—PGR—uterus—germ cell cancer	0.00618	0.0187	CbGeAlD
Etonogestrel—PGR—pituitary gland—germ cell cancer	0.00607	0.0183	CbGeAlD
Etonogestrel—SHBG—adrenal gland—germ cell cancer	0.00602	0.0182	CbGeAlD
Etonogestrel—ESR1—telencephalon—germ cell cancer	0.00583	0.0176	CbGeAlD
Etonogestrel—SHBG—bone marrow—germ cell cancer	0.00582	0.0176	CbGeAlD
Etonogestrel—SHBG—female gonad—germ cell cancer	0.00561	0.0169	CbGeAlD
Etonogestrel—ESR1—decidua—germ cell cancer	0.00553	0.0167	CbGeAlD
Etonogestrel—PGR—adrenal gland—germ cell cancer	0.00542	0.0164	CbGeAlD
Etonogestrel—SHBG—endocrine gland—germ cell cancer	0.00522	0.0158	CbGeAlD
Etonogestrel—PGR—female gonad—germ cell cancer	0.00506	0.0153	CbGeAlD
Etonogestrel—SHBG—testis—germ cell cancer	0.00498	0.015	CbGeAlD
Etonogestrel—ESR1—gonad—germ cell cancer	0.00487	0.0147	CbGeAlD
Etonogestrel—ESR1—uterus—germ cell cancer	0.00483	0.0146	CbGeAlD
Etonogestrel—ESR1—pituitary gland—germ cell cancer	0.00475	0.0143	CbGeAlD
Etonogestrel—PGR—endocrine gland—germ cell cancer	0.0047	0.0142	CbGeAlD
Etonogestrel—PGR—head—germ cell cancer	0.00464	0.014	CbGeAlD
Etonogestrel—PGR—Nuclear Receptors—NR0B1—germ cell cancer	0.00461	0.141	CbGpPWpGaD
Etonogestrel—SHBG—cerebellum—germ cell cancer	0.0046	0.0139	CbGeAlD
Etonogestrel—PGR—testis—germ cell cancer	0.00448	0.0135	CbGeAlD
Etonogestrel—ESR1—adrenal gland—germ cell cancer	0.00424	0.0128	CbGeAlD
Etonogestrel—PGR—cerebellum—germ cell cancer	0.00414	0.0125	CbGeAlD
Etonogestrel—ESR1—female gonad—germ cell cancer	0.00395	0.0119	CbGeAlD
Etonogestrel—PGR—Ovarian Infertility Genes—INHA—germ cell cancer	0.0039	0.119	CbGpPWpGaD
Etonogestrel—SHBG—brain—germ cell cancer	0.00373	0.0113	CbGeAlD
Etonogestrel—ESR1—endocrine gland—germ cell cancer	0.00368	0.0111	CbGeAlD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00364	0.111	CbGpPWpGaD
Etonogestrel—ESR1—head—germ cell cancer	0.00363	0.011	CbGeAlD
Etonogestrel—ESR1—testis—germ cell cancer	0.00351	0.0106	CbGeAlD
Etonogestrel—PGR—brain—germ cell cancer	0.00336	0.0102	CbGeAlD
Etonogestrel—PGR—lymph node—germ cell cancer	0.00325	0.00981	CbGeAlD
Etonogestrel—ESR1—cerebellum—germ cell cancer	0.00324	0.00978	CbGeAlD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.00304	0.0928	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptors—NR0B1—germ cell cancer	0.00271	0.0827	CbGpPWpGaD
Etonogestrel—ESR1—brain—germ cell cancer	0.00263	0.00794	CbGeAlD
Etonogestrel—ESR1—lymph node—germ cell cancer	0.00254	0.00767	CbGeAlD
Etonogestrel—Cystitis noninfective—Methotrexate—germ cell cancer	0.00245	0.00385	CcSEcCtD
Etonogestrel—Malaise—Bleomycin—germ cell cancer	0.00244	0.00384	CcSEcCtD
Etonogestrel—Cystitis—Methotrexate—germ cell cancer	0.00242	0.0038	CcSEcCtD
Etonogestrel—Angiopathy—Ifosfamide—germ cell cancer	0.00241	0.00379	CcSEcCtD
Etonogestrel—Immune system disorder—Ifosfamide—germ cell cancer	0.0024	0.00377	CcSEcCtD
Etonogestrel—Vaginal infection—Methotrexate—germ cell cancer	0.00236	0.00372	CcSEcCtD
Etonogestrel—Cough—Bleomycin—germ cell cancer	0.00236	0.00371	CcSEcCtD
Etonogestrel—Paraesthesia—Vinblastine—germ cell cancer	0.00235	0.00369	CcSEcCtD
Etonogestrel—Alopecia—Ifosfamide—germ cell cancer	0.00235	0.00369	CcSEcCtD
Etonogestrel—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00234	0.00368	CcSEcCtD
Etonogestrel—Infestation NOS—Etoposide—germ cell cancer	0.00234	0.00368	CcSEcCtD
Etonogestrel—Infestation—Etoposide—germ cell cancer	0.00234	0.00368	CcSEcCtD
Etonogestrel—Mental disorder—Ifosfamide—germ cell cancer	0.00233	0.00366	CcSEcCtD
Etonogestrel—Erythema—Ifosfamide—germ cell cancer	0.00231	0.00364	CcSEcCtD
Etonogestrel—Malnutrition—Ifosfamide—germ cell cancer	0.00231	0.00364	CcSEcCtD
Etonogestrel—Myalgia—Bleomycin—germ cell cancer	0.00231	0.00362	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Etoposide—germ cell cancer	0.00229	0.0036	CcSEcCtD
Etonogestrel—Discomfort—Bleomycin—germ cell cancer	0.00228	0.00358	CcSEcCtD
Etonogestrel—Malaise—Dactinomycin—germ cell cancer	0.00228	0.00358	CcSEcCtD
Etonogestrel—Decreased appetite—Vinblastine—germ cell cancer	0.00227	0.00358	CcSEcCtD
Etonogestrel—Neoplasm—Methotrexate—germ cell cancer	0.00226	0.00356	CcSEcCtD
Etonogestrel—Bladder pain—Methotrexate—germ cell cancer	0.00226	0.00356	CcSEcCtD
Etonogestrel—Urinary tract disorder—Cisplatin—germ cell cancer	0.00226	0.00356	CcSEcCtD
Etonogestrel—Connective tissue disorder—Cisplatin—germ cell cancer	0.00225	0.00354	CcSEcCtD
Etonogestrel—Urethral disorder—Cisplatin—germ cell cancer	0.00225	0.00353	CcSEcCtD
Etonogestrel—Constipation—Vinblastine—germ cell cancer	0.00224	0.00352	CcSEcCtD
Etonogestrel—Pain—Vinblastine—germ cell cancer	0.00224	0.00352	CcSEcCtD
Etonogestrel—Anaphylactic shock—Bleomycin—germ cell cancer	0.00221	0.00347	CcSEcCtD
Etonogestrel—Oedema—Bleomycin—germ cell cancer	0.00221	0.00347	CcSEcCtD
Etonogestrel—Visual impairment—Cisplatin—germ cell cancer	0.00221	0.00347	CcSEcCtD
Etonogestrel—Infection—Bleomycin—germ cell cancer	0.0022	0.00345	CcSEcCtD
Etonogestrel—Feeling abnormal—Vinblastine—germ cell cancer	0.00216	0.00339	CcSEcCtD
Etonogestrel—Myalgia—Dactinomycin—germ cell cancer	0.00215	0.00338	CcSEcCtD
Etonogestrel—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00215	0.00338	CcSEcCtD
Etonogestrel—Eye disorder—Cisplatin—germ cell cancer	0.00214	0.00337	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00214	0.00336	CcSEcCtD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00214	0.0653	CbGpPWpGaD
Etonogestrel—Discomfort—Dactinomycin—germ cell cancer	0.00212	0.00334	CcSEcCtD
Etonogestrel—Angioedema—Ifosfamide—germ cell cancer	0.00211	0.00332	CcSEcCtD
Etonogestrel—Anorexia—Bleomycin—germ cell cancer	0.00211	0.00331	CcSEcCtD
Etonogestrel—Hypoaesthesia—Etoposide—germ cell cancer	0.00209	0.00328	CcSEcCtD
Etonogestrel—Malaise—Ifosfamide—germ cell cancer	0.00209	0.00328	CcSEcCtD
Etonogestrel—Urinary tract disorder—Etoposide—germ cell cancer	0.00207	0.00326	CcSEcCtD
Etonogestrel—Immune system disorder—Cisplatin—germ cell cancer	0.00207	0.00325	CcSEcCtD
Etonogestrel—Abdominal pain—Vinblastine—germ cell cancer	0.00207	0.00325	CcSEcCtD
Etonogestrel—Oedema—Dactinomycin—germ cell cancer	0.00206	0.00324	CcSEcCtD
Etonogestrel—Urethral disorder—Etoposide—germ cell cancer	0.00206	0.00324	CcSEcCtD
Etonogestrel—CYP3A4—endocrine gland—germ cell cancer	0.00205	0.00619	CbGeAlD
Etonogestrel—Infection—Dactinomycin—germ cell cancer	0.00205	0.00322	CcSEcCtD
Etonogestrel—Alopecia—Cisplatin—germ cell cancer	0.00203	0.00318	CcSEcCtD
Etonogestrel—Cough—Ifosfamide—germ cell cancer	0.00202	0.00317	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00201	0.00317	CcSEcCtD
Etonogestrel—Convulsion—Ifosfamide—germ cell cancer	0.002	0.00315	CcSEcCtD
Etonogestrel—Hypertension—Ifosfamide—germ cell cancer	0.002	0.00314	CcSEcCtD
Etonogestrel—Malnutrition—Cisplatin—germ cell cancer	0.00199	0.00314	CcSEcCtD
Etonogestrel—Erythema—Cisplatin—germ cell cancer	0.00199	0.00314	CcSEcCtD
Etonogestrel—Paraesthesia—Bleomycin—germ cell cancer	0.00198	0.00312	CcSEcCtD
Etonogestrel—Arthralgia—Ifosfamide—germ cell cancer	0.00197	0.0031	CcSEcCtD
Etonogestrel—Myalgia—Ifosfamide—germ cell cancer	0.00197	0.0031	CcSEcCtD
Etonogestrel—Flatulence—Cisplatin—germ cell cancer	0.00197	0.00309	CcSEcCtD
Etonogestrel—Anorexia—Dactinomycin—germ cell cancer	0.00196	0.00309	CcSEcCtD
Etonogestrel—Eye disorder—Etoposide—germ cell cancer	0.00196	0.00308	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00196	0.00308	CcSEcCtD
Etonogestrel—Discomfort—Ifosfamide—germ cell cancer	0.00195	0.00306	CcSEcCtD
Etonogestrel—Hypersensitivity—Vinblastine—germ cell cancer	0.00193	0.00303	CcSEcCtD
Etonogestrel—Decreased appetite—Bleomycin—germ cell cancer	0.00192	0.00302	CcSEcCtD
Etonogestrel—Visual disturbance—Methotrexate—germ cell cancer	0.00192	0.00302	CcSEcCtD
Etonogestrel—Muscle spasms—Cisplatin—germ cell cancer	0.00192	0.00302	CcSEcCtD
Etonogestrel—Angiopathy—Etoposide—germ cell cancer	0.0019	0.00299	CcSEcCtD
Etonogestrel—Immune system disorder—Etoposide—germ cell cancer	0.0019	0.00298	CcSEcCtD
Etonogestrel—Pain—Bleomycin—germ cell cancer	0.00189	0.00297	CcSEcCtD
Etonogestrel—Oedema—Ifosfamide—germ cell cancer	0.00189	0.00297	CcSEcCtD
Etonogestrel—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00189	0.00297	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00188	0.00295	CcSEcCtD
Etonogestrel—Asthenia—Vinblastine—germ cell cancer	0.00188	0.00295	CcSEcCtD
Etonogestrel—Infection—Ifosfamide—germ cell cancer	0.00188	0.00295	CcSEcCtD
Etonogestrel—Alopecia—Etoposide—germ cell cancer	0.00186	0.00292	CcSEcCtD
Etonogestrel—Nervous system disorder—Ifosfamide—germ cell cancer	0.00185	0.00291	CcSEcCtD
Etonogestrel—Ill-defined disorder—Cisplatin—germ cell cancer	0.00185	0.00291	CcSEcCtD
Etonogestrel—Skin disorder—Ifosfamide—germ cell cancer	0.00183	0.00288	CcSEcCtD
Etonogestrel—Feeling abnormal—Bleomycin—germ cell cancer	0.00182	0.00286	CcSEcCtD
Etonogestrel—Anorexia—Ifosfamide—germ cell cancer	0.0018	0.00283	CcSEcCtD
Etonogestrel—Malaise—Cisplatin—germ cell cancer	0.0018	0.00283	CcSEcCtD
Etonogestrel—Decreased appetite—Dactinomycin—germ cell cancer	0.00179	0.00282	CcSEcCtD
Etonogestrel—Diarrhoea—Vinblastine—germ cell cancer	0.00179	0.00281	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.00178	0.0545	CbGpPWpGaD
Etonogestrel—Fatigue—Dactinomycin—germ cell cancer	0.00178	0.00279	CcSEcCtD
Etonogestrel—Back pain—Etoposide—germ cell cancer	0.00177	0.00278	CcSEcCtD
Etonogestrel—Pain—Dactinomycin—germ cell cancer	0.00176	0.00277	CcSEcCtD
Etonogestrel—Muscle spasms—Etoposide—germ cell cancer	0.00176	0.00276	CcSEcCtD
Etonogestrel—Urticaria—Bleomycin—germ cell cancer	0.00176	0.00276	CcSEcCtD
Etonogestrel—Body temperature increased—Bleomycin—germ cell cancer	0.00175	0.00275	CcSEcCtD
Etonogestrel—Irritability—Methotrexate—germ cell cancer	0.00173	0.00273	CcSEcCtD
Etonogestrel—Dizziness—Vinblastine—germ cell cancer	0.00173	0.00272	CcSEcCtD
Etonogestrel—Convulsion—Cisplatin—germ cell cancer	0.00173	0.00272	CcSEcCtD
Etonogestrel—Mood swings—Methotrexate—germ cell cancer	0.00172	0.00271	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00172	0.00271	CcSEcCtD
Etonogestrel—Myalgia—Cisplatin—germ cell cancer	0.0017	0.00267	CcSEcCtD
Etonogestrel—Feeling abnormal—Dactinomycin—germ cell cancer	0.0017	0.00267	CcSEcCtD
Etonogestrel—Paraesthesia—Ifosfamide—germ cell cancer	0.0017	0.00267	CcSEcCtD
Etonogestrel—Ill-defined disorder—Etoposide—germ cell cancer	0.0017	0.00267	CcSEcCtD
Etonogestrel—Anxiety—Cisplatin—germ cell cancer	0.00169	0.00266	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00169	0.00265	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00169	0.00265	CcSEcCtD
Etonogestrel—Somnolence—Ifosfamide—germ cell cancer	0.00168	0.00264	CcSEcCtD
Etonogestrel—Discomfort—Cisplatin—germ cell cancer	0.00168	0.00264	CcSEcCtD
Etonogestrel—Vomiting—Vinblastine—germ cell cancer	0.00166	0.00262	CcSEcCtD
Etonogestrel—Malaise—Etoposide—germ cell cancer	0.00165	0.00259	CcSEcCtD
Etonogestrel—Breast disorder—Methotrexate—germ cell cancer	0.00164	0.00258	CcSEcCtD
Etonogestrel—Decreased appetite—Ifosfamide—germ cell cancer	0.00164	0.00258	CcSEcCtD
Etonogestrel—Headache—Vinblastine—germ cell cancer	0.00164	0.00258	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00163	0.00256	CcSEcCtD
Etonogestrel—Abdominal pain—Dactinomycin—germ cell cancer	0.00163	0.00256	CcSEcCtD
Etonogestrel—Body temperature increased—Dactinomycin—germ cell cancer	0.00163	0.00256	CcSEcCtD
Etonogestrel—Fatigue—Ifosfamide—germ cell cancer	0.00163	0.00256	CcSEcCtD
Etonogestrel—Anaphylactic shock—Cisplatin—germ cell cancer	0.00163	0.00256	CcSEcCtD
Etonogestrel—Oedema—Cisplatin—germ cell cancer	0.00163	0.00256	CcSEcCtD
Etonogestrel—Hypersensitivity—Bleomycin—germ cell cancer	0.00163	0.00256	CcSEcCtD
Etonogestrel—Infection—Cisplatin—germ cell cancer	0.00162	0.00254	CcSEcCtD
Etonogestrel—Pain—Ifosfamide—germ cell cancer	0.00161	0.00254	CcSEcCtD
Etonogestrel—Constipation—Ifosfamide—germ cell cancer	0.00161	0.00254	CcSEcCtD
Etonogestrel—Nervous system disorder—Cisplatin—germ cell cancer	0.0016	0.00251	CcSEcCtD
Etonogestrel—Cough—Etoposide—germ cell cancer	0.00159	0.00251	CcSEcCtD
Etonogestrel—Asthenia—Bleomycin—germ cell cancer	0.00159	0.00249	CcSEcCtD
Etonogestrel—Convulsion—Etoposide—germ cell cancer	0.00158	0.00249	CcSEcCtD
Etonogestrel—Skin disorder—Cisplatin—germ cell cancer	0.00158	0.00249	CcSEcCtD
Etonogestrel—Hypertension—Etoposide—germ cell cancer	0.00158	0.00248	CcSEcCtD
Etonogestrel—Asthma—Methotrexate—germ cell cancer	0.00157	0.00247	CcSEcCtD
Etonogestrel—Pruritus—Bleomycin—germ cell cancer	0.00156	0.00246	CcSEcCtD
Etonogestrel—Feeling abnormal—Ifosfamide—germ cell cancer	0.00156	0.00245	CcSEcCtD
Etonogestrel—Nausea—Vinblastine—germ cell cancer	0.00155	0.00244	CcSEcCtD
Etonogestrel—Anorexia—Cisplatin—germ cell cancer	0.00155	0.00244	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00155	0.00243	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00154	0.00243	CcSEcCtD
Etonogestrel—Discomfort—Etoposide—germ cell cancer	0.00154	0.00242	CcSEcCtD
Etonogestrel—Hypersensitivity—Dactinomycin—germ cell cancer	0.00152	0.00239	CcSEcCtD
Etonogestrel—Urticaria—Ifosfamide—germ cell cancer	0.0015	0.00236	CcSEcCtD
Etonogestrel—Abdominal pain—Ifosfamide—germ cell cancer	0.00149	0.00235	CcSEcCtD
Etonogestrel—Body temperature increased—Ifosfamide—germ cell cancer	0.00149	0.00235	CcSEcCtD
Etonogestrel—Anaphylactic shock—Etoposide—germ cell cancer	0.00149	0.00235	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00148	0.00233	CcSEcCtD
Etonogestrel—Infection—Etoposide—germ cell cancer	0.00148	0.00233	CcSEcCtD
Etonogestrel—Asthenia—Dactinomycin—germ cell cancer	0.00148	0.00232	CcSEcCtD
Etonogestrel—Dysuria—Methotrexate—germ cell cancer	0.00147	0.00231	CcSEcCtD
Etonogestrel—Paraesthesia—Cisplatin—germ cell cancer	0.00146	0.0023	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00146	0.0023	CcSEcCtD
Etonogestrel—Skin disorder—Etoposide—germ cell cancer	0.00145	0.00228	CcSEcCtD
Etonogestrel—Anorexia—Etoposide—germ cell cancer	0.00142	0.00224	CcSEcCtD
Etonogestrel—Decreased appetite—Cisplatin—germ cell cancer	0.00142	0.00223	CcSEcCtD
Etonogestrel—Diarrhoea—Dactinomycin—germ cell cancer	0.00141	0.00222	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00141	0.00221	CcSEcCtD
Etonogestrel—Vomiting—Bleomycin—germ cell cancer	0.0014	0.00221	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—germ cell cancer	0.0014	0.0022	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—germ cell cancer	0.0014	0.0022	CcSEcCtD
Etonogestrel—Depression—Methotrexate—germ cell cancer	0.0014	0.0022	CcSEcCtD
Etonogestrel—Rash—Bleomycin—germ cell cancer	0.00139	0.00219	CcSEcCtD
Etonogestrel—Pain—Cisplatin—germ cell cancer	0.00139	0.00219	CcSEcCtD
Etonogestrel—Dermatitis—Bleomycin—germ cell cancer	0.00139	0.00219	CcSEcCtD
Etonogestrel—Hypersensitivity—Ifosfamide—germ cell cancer	0.00139	0.00219	CcSEcCtD
Etonogestrel—Asthenia—Ifosfamide—germ cell cancer	0.00135	0.00213	CcSEcCtD
Etonogestrel—Feeling abnormal—Cisplatin—germ cell cancer	0.00134	0.00211	CcSEcCtD
Etonogestrel—Paraesthesia—Etoposide—germ cell cancer	0.00134	0.00211	CcSEcCtD
Etonogestrel—Pruritus—Ifosfamide—germ cell cancer	0.00134	0.0021	CcSEcCtD
Etonogestrel—Somnolence—Etoposide—germ cell cancer	0.00133	0.00208	CcSEcCtD
Etonogestrel—Nausea—Bleomycin—germ cell cancer	0.00131	0.00206	CcSEcCtD
Etonogestrel—Vomiting—Dactinomycin—germ cell cancer	0.00131	0.00206	CcSEcCtD
Etonogestrel—Rash—Dactinomycin—germ cell cancer	0.0013	0.00204	CcSEcCtD
Etonogestrel—Decreased appetite—Etoposide—germ cell cancer	0.0013	0.00204	CcSEcCtD
Etonogestrel—Diarrhoea—Ifosfamide—germ cell cancer	0.00129	0.00203	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00129	0.00202	CcSEcCtD
Etonogestrel—Body temperature increased—Cisplatin—germ cell cancer	0.00129	0.00202	CcSEcCtD
Etonogestrel—Fatigue—Etoposide—germ cell cancer	0.00129	0.00202	CcSEcCtD
Etonogestrel—Constipation—Etoposide—germ cell cancer	0.00128	0.00201	CcSEcCtD
Etonogestrel—Pain—Etoposide—germ cell cancer	0.00128	0.00201	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—germ cell cancer	0.00126	0.00199	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—germ cell cancer	0.00126	0.00198	CcSEcCtD
Etonogestrel—Dizziness—Ifosfamide—germ cell cancer	0.00125	0.00196	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—germ cell cancer	0.00125	0.00196	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—germ cell cancer	0.00124	0.00195	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—germ cell cancer	0.00123	0.00194	CcSEcCtD
Etonogestrel—Feeling abnormal—Etoposide—germ cell cancer	0.00123	0.00193	CcSEcCtD
Etonogestrel—Nausea—Dactinomycin—germ cell cancer	0.00122	0.00192	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Etoposide—germ cell cancer	0.00122	0.00192	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—germ cell cancer	0.00121	0.00191	CcSEcCtD
Etonogestrel—Vomiting—Ifosfamide—germ cell cancer	0.0012	0.00189	CcSEcCtD
Etonogestrel—Hypersensitivity—Cisplatin—germ cell cancer	0.0012	0.00189	CcSEcCtD
Etonogestrel—Rash—Ifosfamide—germ cell cancer	0.00119	0.00187	CcSEcCtD
Etonogestrel—Dermatitis—Ifosfamide—germ cell cancer	0.00119	0.00187	CcSEcCtD
Etonogestrel—Urticaria—Etoposide—germ cell cancer	0.00118	0.00186	CcSEcCtD
Etonogestrel—Body temperature increased—Etoposide—germ cell cancer	0.00118	0.00185	CcSEcCtD
Etonogestrel—Abdominal pain—Etoposide—germ cell cancer	0.00118	0.00185	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—germ cell cancer	0.00118	0.00185	CcSEcCtD
Etonogestrel—Asthenia—Cisplatin—germ cell cancer	0.00117	0.00184	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—germ cell cancer	0.00114	0.00179	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—germ cell cancer	0.00114	0.00179	CcSEcCtD
Etonogestrel—Nausea—Ifosfamide—germ cell cancer	0.00112	0.00176	CcSEcCtD
Etonogestrel—Diarrhoea—Cisplatin—germ cell cancer	0.00111	0.00175	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—germ cell cancer	0.00111	0.00175	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—germ cell cancer	0.0011	0.00173	CcSEcCtD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—germ cell cancer	0.0011	0.0336	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Etoposide—germ cell cancer	0.0011	0.00173	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—germ cell cancer	0.00109	0.00172	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—germ cell cancer	0.00109	0.00172	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—germ cell cancer	0.00107	0.00168	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—germ cell cancer	0.00106	0.00166	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—germ cell cancer	0.00106	0.00166	CcSEcCtD
Etonogestrel—Vomiting—Cisplatin—germ cell cancer	0.00104	0.00163	CcSEcCtD
Etonogestrel—Rash—Cisplatin—germ cell cancer	0.00103	0.00161	CcSEcCtD
Etonogestrel—Dermatitis—Cisplatin—germ cell cancer	0.00103	0.00161	CcSEcCtD
Etonogestrel—Diarrhoea—Etoposide—germ cell cancer	0.00102	0.0016	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—germ cell cancer	0.00102	0.0016	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—germ cell cancer	0.000987	0.00155	CcSEcCtD
Etonogestrel—Dizziness—Etoposide—germ cell cancer	0.000986	0.00155	CcSEcCtD
Etonogestrel—Nausea—Cisplatin—germ cell cancer	0.000967	0.00152	CcSEcCtD
Etonogestrel—Cough—Methotrexate—germ cell cancer	0.000955	0.0015	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—germ cell cancer	0.000948	0.00149	CcSEcCtD
Etonogestrel—Vomiting—Etoposide—germ cell cancer	0.000948	0.00149	CcSEcCtD
Etonogestrel—Rash—Etoposide—germ cell cancer	0.00094	0.00148	CcSEcCtD
Etonogestrel—Dermatitis—Etoposide—germ cell cancer	0.00094	0.00148	CcSEcCtD
Etonogestrel—Headache—Etoposide—germ cell cancer	0.000934	0.00147	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—germ cell cancer	0.000932	0.00147	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—germ cell cancer	0.000932	0.00147	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000926	0.00146	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—germ cell cancer	0.000921	0.00145	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—germ cell cancer	0.000893	0.0014	CcSEcCtD
Etonogestrel—Infection—Methotrexate—germ cell cancer	0.000888	0.0014	CcSEcCtD
Etonogestrel—Nausea—Etoposide—germ cell cancer	0.000886	0.00139	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—germ cell cancer	0.000876	0.00138	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—germ cell cancer	0.000868	0.00136	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—germ cell cancer	0.000852	0.00134	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000814	0.00128	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—germ cell cancer	0.000808	0.00127	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—germ cell cancer	0.000802	0.00126	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—germ cell cancer	0.000794	0.00125	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—germ cell cancer	0.000786	0.00124	CcSEcCtD
Etonogestrel—Decreased appetite—Methotrexate—germ cell cancer	0.000777	0.00122	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000771	0.00121	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—germ cell cancer	0.00077	0.00121	CcSEcCtD
Etonogestrel—Pain—Methotrexate—germ cell cancer	0.000764	0.0012	CcSEcCtD
Etonogestrel—Feeling abnormal—Methotrexate—germ cell cancer	0.000736	0.00116	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000731	0.00115	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—germ cell cancer	0.00071	0.00112	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—germ cell cancer	0.000706	0.00111	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—germ cell cancer	0.000706	0.00111	CcSEcCtD
Etonogestrel—Hypersensitivity—Methotrexate—germ cell cancer	0.000658	0.00103	CcSEcCtD
Etonogestrel—Asthenia—Methotrexate—germ cell cancer	0.000641	0.00101	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—germ cell cancer	0.000632	0.000994	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000629	0.0192	CbGpPWpGaD
Etonogestrel—Diarrhoea—Methotrexate—germ cell cancer	0.000611	0.000961	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—germ cell cancer	0.000591	0.000929	CcSEcCtD
Etonogestrel—Vomiting—Methotrexate—germ cell cancer	0.000568	0.000893	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000566	0.0173	CbGpPWpGaD
Etonogestrel—Rash—Methotrexate—germ cell cancer	0.000563	0.000886	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—germ cell cancer	0.000563	0.000885	CcSEcCtD
Etonogestrel—Headache—Methotrexate—germ cell cancer	0.00056	0.00088	CcSEcCtD
Etonogestrel—Nausea—Methotrexate—germ cell cancer	0.000531	0.000834	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—FGF4—germ cell cancer	0.000517	0.0158	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—KITLG—germ cell cancer	0.000425	0.013	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000369	0.0113	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	0.000318	0.00973	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—FGFR3—germ cell cancer	0.000316	0.00964	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—FGF4—germ cell cancer	0.000303	0.00927	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NR0B1—germ cell cancer	0.000303	0.00926	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—KIT—germ cell cancer	0.00029	0.00885	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—DNMT3L—germ cell cancer	0.000263	0.00803	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—MYC—germ cell cancer	0.000262	0.008	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—MYC—germ cell cancer	0.000257	0.00785	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KITLG—germ cell cancer	0.000249	0.00761	CbGpPWpGaD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000249	0.0076	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RARS—germ cell cancer	0.000244	0.00746	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000243	0.00744	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—TP53—germ cell cancer	0.000211	0.00645	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—germ cell cancer	0.00021	0.0064	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000191	0.00584	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	0.000187	0.00571	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—FGFR3—germ cell cancer	0.000185	0.00566	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—germ cell cancer	0.000178	0.00544	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR0B1—germ cell cancer	0.000178	0.00543	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—germ cell cancer	0.000174	0.00532	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KIT—germ cell cancer	0.00017	0.0052	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	0.000155	0.00473	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—DNMT3L—germ cell cancer	0.000154	0.00471	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RARS—germ cell cancer	0.000143	0.00438	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—germ cell cancer	0.000143	0.00437	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—HRAS—germ cell cancer	0.000129	0.00395	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—HRAS—germ cell cancer	0.000125	0.00383	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	9.41e-05	0.00287	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—H2AFZ—germ cell cancer	9.19e-05	0.00281	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—OXT—germ cell cancer	7.84e-05	0.0024	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	7.79e-05	0.00238	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	7.72e-05	0.00236	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—germ cell cancer	7.35e-05	0.00225	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF4—germ cell cancer	6.69e-05	0.00205	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—germ cell cancer	6.6e-05	0.00202	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	6.4e-05	0.00196	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—H2AFZ—germ cell cancer	5.98e-05	0.00183	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KITLG—germ cell cancer	5.5e-05	0.00168	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—H2AFZ—germ cell cancer	5.4e-05	0.00165	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AVP—germ cell cancer	5.38e-05	0.00164	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—OXT—germ cell cancer	4.6e-05	0.00141	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGFR3—germ cell cancer	4.09e-05	0.00125	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF4—germ cell cancer	3.93e-05	0.0012	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—germ cell cancer	3.87e-05	0.00118	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KIT—germ cell cancer	3.75e-05	0.00115	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—H2AFZ—germ cell cancer	3.51e-05	0.00107	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KITLG—germ cell cancer	3.23e-05	0.000986	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—germ cell cancer	3.18e-05	0.00097	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AVP—germ cell cancer	3.15e-05	0.000964	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.67e-05	0.000815	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.63e-05	0.000803	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGFR3—germ cell cancer	2.4e-05	0.000733	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KIT—germ cell cancer	2.2e-05	0.000673	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CRABP1—germ cell cancer	2.14e-05	0.000654	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—germ cell cancer	2.06e-05	0.000631	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—germ cell cancer	1.86e-05	0.000569	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—germ cell cancer	1.7e-05	0.000518	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—germ cell cancer	1.62e-05	0.000496	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—germ cell cancer	1.21e-05	0.00037	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—germ cell cancer	9.95e-06	0.000304	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—germ cell cancer	9.52e-06	0.000291	CbGpPWpGaD
